An experimental stem cell treatment is being investigated for multiple sclerosis.
An innovative stem cell therapy could change how we treat multiple sclerosis (MS), but are we any closer to a cure?
The work of Dr. Su Metcalfe, founder and chief scientific officer of the biotech company LIFNano, appears to be breathing new life into that hope.
Metcalfe and her team developed a way to fight MS by using the body’s own natural mechanisms — but it hasn’t been tested in humans yet.
MS is an inflammatory and neurodegenerative autoimmune disease that can result in an array of neurological symptoms including fatigue, muscle spasms, speech problems, and numbness. It is caused by the immune system attacking myelin, the insulating coating that runs along the outside of nerve cells. The result is damage to the brain and central nervous system.
The disease currently affects roughly 2.5 million people worldwide. About 200 new cases are diagnosed each week in the United States.
Read full article: Multiple Sclerosis Remission and Stem Cell Therapy
|Read Full Article: Multiple Sclerosis Remission and Stem Cell Therapy|